Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways
Tóm tắt
Từ khóa
Tài liệu tham khảo
Goltzman, 2002, Discoveries, drugs and skeletal disorders, Nat. Rev., Drug Discov., 1, 784, 10.1038/nrd916
Manolagas, 2000, Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis, Endocr. Rev., 21, 115, 10.1210/er.21.2.115
Duque, 2002, Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation, Biochem. Biophys. Res. Commun., 299, 446, 10.1016/S0006-291X(02)02657-8
Hughes, 1996, Estrogen promotes apoptosis of murine osteoclasts mediated by TGFß, Nat. Med., 2, 1132, 10.1038/nm1096-1132
Weinstein, 2002, Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids, J. Clin. Invest., 109, 1041, 10.1172/JCI0214538
Hill, 1997, Multiple extracellular signals promote osteoblast survival and apoptosis, Endocrinology, 138, 3849, 10.1210/en.138.9.3849
Kawakami, 1997, Fas and Fas ligand interaction is necessary for human osteoblast apoptosis, J. Bone Miner. Res., 12, 1637, 10.1359/jbmr.1997.12.10.1637
Tsuboi, 1999, Fas and Fas ligand interaction is necessary for human osteoblast apoptosis, J. Lab. Clin. Med., 134, 222, 10.1016/S0022-2143(99)90201-9
Chao, 2002, Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis, J. Biol. Chem., 277, 31639, 10.1074/jbc.M204104200
Kawakami, 1998, Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts, Biochem. Biophys. Res. Commun., 247, 46, 10.1006/bbrc.1998.8728
Kischkel, 1995, Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signalling complex (DISC) with the receptor, EMBO J., 14, 5579, 10.1002/j.1460-2075.1995.tb00245.x
Ozeki, 2002, Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells, Arch. Oral Biol., 47, 511, 10.1016/S0003-9969(02)00035-3
Bang, 2000, Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction, J. Biol. Chem., 275, 36217, 10.1074/jbc.M006620200
Norman, 1982, Intestinal calcium transport: pleiotropic effects mediated by vitamin D, Fed. Proc., 41, 78
Ozono, 1991, Perspectives: the genomic mechanism of action of 1,25-dihydroxyvitamin D3, J. Bone Miner. Res., 6, 1021, 10.1002/jbmr.5650061002
Clements, 1992, Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis, Clin. Endocrinol. (Oxf.), 37, 17, 10.1111/j.1365-2265.1992.tb02278.x
Lips, 2001, Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications, Endocr. Rev., 22, 477, 10.1210/er.22.4.477
Burgess, 1999, The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts, J. Cell Biol., 145, 527, 10.1083/jcb.145.3.527
O'Brien, 1999, Identification of an OSF-2 binding site in the murine RANKL/OPGL gene promoter: a potential link between osteoblastogenesis and osteoclastogenesis, J. Biol. Chem., 274, 19301, 10.1074/jbc.274.27.19301
De Pollack, 1996, Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis), J. Bone Miner. Res., 11, 401, 10.1002/jbmr.5650110314
Lomri, 1999, Genomic insertion of the SV-40 large T oncogene in normal adult human trabecular osteoblastic cells induces cell growth without loss of the differentiated phenotype, Calcif. Tissue Int., 64, 394, 10.1007/PL00005821
Lomri, 1997, Expression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in newborn human calvaria osteoblastic cells, Eur. J. Endocrinol., 136, 640, 10.1530/eje.0.1360640
Gavrieli, 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J. Cell Biol., 119, 493, 10.1083/jcb.119.3.493
Jilka, 1999, Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone, J. Clin. Invest., 104, 439, 10.1172/JCI6610
Luckman, 1998, Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras, J. Bone Miner. Res., 13, 581, 10.1359/jbmr.1998.13.4.581
Cooper, 2000, Estrogen-induced resistance to osteoblast apoptosis is associated with increased hsp27 expression, J. Cell. Physiol., 185, 401, 10.1002/1097-4652(200012)185:3<401::AID-JCP10>3.0.CO;2-C
Jilka, 1998, Osteoblast programmed cell death (Apoptosis): modulation by growth factors and cytokines, J. Bone Miner. Res., 13, 793, 10.1359/jbmr.1998.13.5.793
Urayama, 2000, Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine, J. Lab. Clin. Med., 136, 181, 10.1067/mlc.2000.108754
Schilli, 1998, Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs, J. Invest. Dermatol., 111, 598, 10.1046/j.1523-1747.1998.00350.x
Niikura, 2002, Monitoring of caspase-8/FLICE processing and activation upon Fas stimulation with novel antibodies directed against a cleavage site for caspase-8 and its substrate, FLICE-like inhibitory protein (FLIP), J. Biochem. (Tokyo), 132, 53, 10.1093/oxfordjournals.jbchem.a003198
Hansen, 2001, Vitamin D compounds exert anti-apoptotic effects in human osteosarcoma cells in vitro, J. Steroid Biochem. Mol. Biol., 77, 1, 10.1016/S0960-0760(01)00033-4
Smulson, 2000, Roles of poly (ADP-ribosylation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1, Adv. Enzyme Regul., 40, 183, 10.1016/S0065-2571(99)00024-2
Xu, 2000, p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4, Biochem. Biophys. Res. Commun., 269, 179, 10.1006/bbrc.2000.2247
Suzuki, 1998, Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP, Oncogene, 17, 931, 10.1038/sj.onc.1202021
Bellido, 1998, Transcriptional activation of the p21 (WAF1, CIP1, SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells, J. Biol. Chem., 273, 21137, 10.1074/jbc.273.33.21137